The most ambitious project to find a coronavirus vaccine began today with the presence of 30,000 volunteers willing to receive the dose made by laboratories of the US government.
However, this is not clear whether the trial vaccine created by the National Institutes of Health and Modern Inc. will work accurately or not.
To determine the efficacy of the dose, the volunteers will not know if they are receiving the vaccine or a placebo. After two injections, they will be closely monitored to see which of the two groups develops more infections while continuing with their daily routine, especially in regions where the virus has re-emerged.
“Unfortunately for the United States, we have abundant infections now” to be able to find the answer, declared the director of the Institutes, Dr. Anthony Fauci, in a recent magazine with The Associated Press.
Moderna reported that vaccinations were conducted in Savannah, Georgia, the first of more than 90 sites where the experiment will be conducted.
In Binghamton, A Nurse Melissa Harting stated she volunteered “to do my part, to help.”
“I’m excited to do it,” Harting said before receiving the injection earlier today. She becomes from the Medical Department who may be sensitive to the disease, “doing my part to eradicate it is very important to me.”
Other vaccines, conducted in China and at Oxford University in England, are conducting smaller trials in Brazil and other critically affected countries.
But in the United States, every potential vaccine has to pass strict tests: every month, the Covid-19 Prevention Network, a government-funded initiative, will release a study on a possible vaccine, and each will have to have 30,000 volunteers.
The studies serve not only to see if the vaccine works but also to ensure that they do not have harmful side effects. And the responsibility to submit all doses on the same standards will make it easier for scientists to compare them all.
According to the source, the Final stage trial of the vaccine by Oxford University will start in August.
“Andover leader” will provide further updates when more information is available.